Multiple visual prosthetic projects and other vision regeneration initiatives being tested in preclinical and clinical development worldwide illustrate continuing progress and opportunities in addressing profound blindness from hereditary retinal diseases and other causes (Table 1). Three implantable bionic vision systems...
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...
In 2004 a network of three ophthalmic reading centres in Belfast, London and Liverpool (known as NetwORC UK) was established to form the largest reading centre in Europe for the purpose of providing high quality grading of ophthalmic images for...
Case report A 16-year-old Caucasian male was referred to the eye casualty at Nottingham University Hospitals NHS Trust by the infectious diseases unit in September 2013. He gave a history of photophobia, pain on eye movements and central blurred vision...
This series explores the four pillars of advanced clinical practice and here, Rebecca Turner explores the pillar of clinical research. The role of the ophthalmic advanced nurse practitioner, as with all registered practitioners allied to ophthalmology, is on an upward...
Leading us into July this year will be the 108th Oxford Ophthalmological Congress (OOC), the longest-standing congress dedicated to ophthalmology in the UK. This year, the OOC has attracted the largest number of abstracts it has ever seen in its...
It’s a great honour to be handed the editorial relay baton by Professor Bal Dhillon and I hope I don’t fumble it along the way. As I put pen to paper, I reflect on Bal’s signing off in the last...
Glaucoma UK is launching a new booklet to highlight the services it can offer to people with glaucoma, and the healthcare professionals looking after them.
The International Myopia Institute (IMI) is excited to announce the release of the third series of their highly cited White Papers in a special issue of the top peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.